386 research outputs found
Simulation of cellular irradiation with the CENBG microbeam line using GEANT4
Light-ion microbeams provide a unique opportunity to irradiate biological
samples at the cellular level and to investigate radiobiological effects at low
doses of high LET ionising radiation. Since 1998 a single-ion irradiation
facility has been developed on the focused horizontal microbeam line of the
CENBG 3.5 MV Van de Graaff accelerator. This setup delivers in air single
protons and alpha particles of a few MeV onto cultured cells, with a spatial
resolution of a few microns, allowing subcellular targeting. In this paper, we
present results from the use of the GEANT4 toolkit to simulate cellular
irradiation with the CENBG microbeam line, from the entrance to the microprobe
up to the cellular medium.Comment: 6 pages, 8 figures, presented at the 2003 IEEE-NSS conference,
Portland, OR, USA, October 20-24, 200
Self-DNA Early Exposure in Cultivated and Weedy Setaria Triggers ROS Degradation Signaling Pathways and Root Growth Inhibition
The accumulation of fragmented extracellular DNA reduces conspecific seed germination and plantlet growth in a concentration-dependent manner. This self-DNA inhibition was repeatedly reported, but the underlying mechanisms are not fully clarified. We investigated the species-specificity of self-DNA inhibition in cultivated vs. weed congeneric species (respectively, Setaria italica and S. pumila) and carried out a targeted real-time qPCR analysis under the hypothesis that self-DNA elicits molecular pathways that are responsive to abiotic stressors. The results of a cross-factorial experiment on root elongation of seedlings exposed to self-DNA, congeneric DNA, and heterospecific DNA from Brassica napus and Salmon salar confirmed a significantly higher inhibition by self-DNA as compared to non-self-treatments, with the latter showing a magnitude of the effect consistent with the phylogenetic distance between the DNA source and the target species. Targeted gene expression analysis highlighted an early activation of genes involved in ROS degradation and management (FSD2, ALDH22A1, CSD3, MPK17), as well as deactivation of scaffolding molecules acting as negative regulators of stress signaling pathways (WD40-155). While being the first exploration of early response to self-DNA inhibition at molecular level on C4 model plants, our study highlights the need for further investigation of the relationships between DNA exposure and stress signaling pathways by discussing potential applications for species-specific weed control in agriculture
Fortification of dairy goats’ products with various selenium sources
The aim of this study was to evaluate the effects of two dietary selenium (Se) sources in dairy goat’s milk and cheese. Twentyone
goats were allocated to 3 dietary treatments: control (C) with 0.07 mg of Se/kg dry matter (DM); Se yeast (SeY) with 0.14
mg of total Se/kg DM; and sodium selenite (SeNa) with 0.14 mg of total Se/kg DM supplementation. Individual blood and
milk samples were collected to determine the Se content. Three cheese wheels were made from each group at three different time,
and the Se content was determined. The enumeration of dairy microorganisms was also performed. The SeY group showed
a significantly higher milk Se content (P<0.05) than the SeNa group with 44.71 vs 39.29 μg/l, respectively. Both values were also
significantly higher (P<0.01) than that of the group C (31.19 μg/l). The SeY group showed a significantly higher Se carryover
value (31.29%, P<0.05) than the SeNa group (26.95%). Both values were significantly (P<0.01) lower than in the C group
(49.66%). Significant differences were also observed in cheese Se content among the 3 groups. The average Se content in cheeses
from groups C, SeY, SeNa was 230 μg/kg, 353 μg/kg and 306 μg/kg, respectively. Se yeast supplementation influenced Se
concentration in goat’s milk and cheese but, unlike other authors, we also observed an increase of Se concentration in milk and
cheese supplemented with SeNa, although to a smaller extent. Our results indicate that Se yeast supplementation seems to be
the best fortification source for dairy goat’s products. In several countries the selenium intake is considered to be low in the
human diet, the consumption of Se-enriched products could represent a good way to prevent the deficit in the Se intake currently
reported in many countries
Catalytic asymmetric crotylation of aldehydes: application in total synthesis of (−)‐elisabethadione
A new, highly efficient Lewis base catalyst for
a practical enantio- and diastereoselective crotylation of
unsaturated aldehydes with E- and Z-crotyltrichlorosilanes
has been developed. The method was employed as a key
step in a novel asymmetric synthesis of bioactive serrulatane diterpene (À)-elisabethadione. Other strategic reactions for setting up the stereogenic centers included
anionic oxy-Cope rearrangement and cationic cyclization.
The synthetic route relies on simple, high yielding reactions and avoids use of protecting groups or chiral auxiliaries
EP-1347: Could “radical” RT be a reasonable choice in bone oligometastatic prostate cancer patients?
Correlations between tumor-infiltrating and circulating lymphocyte subpopulations in advanced renal cancer patients treated with nivolumab
Background: In clinical trials with immunotherapy, histological features such as tumor-infiltrating lymphocytes (TILs) are investigated as potential predictive biomarkers, with the limit of an outdated parameter for a typically dynamic element. Methods: This explorative study compared, in metastatic renal cell carcinoma (mRCC) patients, basal pathological data about TILs on diagnostic histological specimens with circulating lymphocyte subpopulations measured before and during therapy with nivolumab. Results: Of 11 mRCC patients, 5 had low presence of TILs (L-TILs), 3 moderate amount (M-TILs) and 3 high number (H-TILs). Overall, 8 patients had low intratumoral pathological CD4+/CD8+ ratio (LIPR) ≤1 and 3 cases high intratumoral pathological ratio (HIPR) ≥2. Of 8 patients with LIPR, only 2 matched with low circulating CD4+/CD8+ ratio (LCR) ≤1; 5 had high circulating ratio (HCR) ≥2. All 3 cases with HIPR (≥2) conversely had LCR (≤1). Circulating CD4+/CD8+ ratio remained unchanged during therapy (mean-0.12 in 8 weeks). The respective percentage values of CD4+ and CD8+ circulating T cells also remained stable (variation 0%); the absolute value of CD4+ was more likely to increase (mean +46.3/mm3); the level of CD8+ tended to slightly decrease (mean-6.5/mm3). No correlation of lymphocyte subpopulations with treatment outcome was found. Of note, we did not evidence correspondence between histopathological and circulating findings in terms of T-lymphocyte subpopulations, also suggesting the inconsistency of circulating data in terms of relative variations. Conclusions: Considering the likely high dynamism of TILs, rebiopsy before therapy might be proposed to assess the utility of TILs characterization for predictive purpose. (www.actabiomedica.it)
Imaging biomarkers in prostate cancer: role of PET/CT and MRI
Prostate-specific antigen (PSA) is currently the most widely used biomarker of prostate cancer (PCa). PSA suggests the presence of primary tumour and disease relapse after treatment, but it is not able to provide a clear distinction between locoregional and distant disease. Molecular and functional imaging, that are able to provide a detailed and comprehensive overview of PCa extension, are more reliable tools for primary tumour detection and disease extension assessment both in staging and restaging. In the present review we evaluate the role of PET/CT and MRI in the diagnosis, staging and restaging of PCa, and the use of these imaging modalities in prognosis, treatment planning and response assessment. Innovative imaging strategies including new radiotracers and hybrid scanners such as PET/MRI are also discussed
Bithiazole Inhibitors of Phosphatidylinositol 4-Kinase (PI4KIIIβ) as Broad-Spectrum Antivirals Blocking the Replication of SARS-CoV-2, Zika Virus, and Human Rhinoviruses
Over half a century since the description of the first antiviral drug, “old” re-emerging viruses and “new” emerging viruses still represent a serious threat to global health. Their high mutation rate and rapid selection of resistance toward common antiviral drugs, together with the increasing number of co-infections, make the war against viruses quite challenging. Herein we report a host-targeted approach, based on the inhibition of the lipid kinase PI4KIIIβ, as a promising strategy for inhibiting the replication of multiple viruses hijacking this protein. We show that bithiazole inhibitors of PI4KIIIβ block the replication of human rhinoviruses (hRV), Zika virus (ZIKV) and SARS-CoV-2 at low micromolar and sub-micromolar concentrations. However, while the anti-hRV/ZIKV activity can be directly linked to PI4KIIIβ inhibition, the role of PI4KIIIβ in SARS-CoV-2 entry/replication is debated
FDG uptake by prosthetic arterial grafts in large vessel vasculitis Is not specific for active disease
OBJECTIVES: This study investigated the incidence and clinical significance of arterial graft-associated uptake of fluorodeoxyglucose in large-vessel vasculitis (LVV). BACKGROUND: The role of (18)F-labeled fluorodeoxyglucose-positron emission tomography/computed tomography ([(18)F]FDG-PET/CT) in the management of LVV remains to be defined. Although [(18)F]FDG uptake at arterial graft sites raises concerns regarding active arteritis or infection, its clinical significance in LVV has never been formally studied. METHODS: An observational prospective study sought to identify patients with Takayasu arteritis (TA) undergoing [(18)F]FDG-PET/CT more than 6 months after graft surgery from a large cohort of patients from 2 tertiary referral centers. [(18)F]FDG uptake by the graft and native arteries was scored on a scale of 0 to 3 relative to hepatic uptake, and periprosthetic maximum standardized uptake value (SUVmax) was calculated. Periprosthetic [(18)F]FDG uptake in active disease was compared with that in inactive disease, and arterial progression was assessed by prospective magnetic resonance angiography (MRA). RESULTS: Twenty-six subjects with TA were enrolled. All were afebrile with negative blood culture. Periprosthetic uptake was significant in 23 of 26 patients, and the mean SUVmax was 4.21 ± 1.46. Median periprosthetic [(18)F]FDG uptake score (3; interquartile range [IQR]: 3 to 3) was higher than in native aorta (1; IQR: 0 to 1; p < 0.001). Graft-specific [(18)F]FDG uptake was unrelated to disease activity. Despite the high frequency of graft-associated [(18)F]FDG uptake, sequential MRAs did not reveal arterial progression in 25 of 26 patients; the 1 remaining case showed minor progression limited to native arteries. Nine patients underwent repeated PET/CT scanning without showing changes in graft-specific uptake, despite increased treatment. CONCLUSIONS: Significant [(18)F]FDG uptake that is confined to arterial graft sites in patients with LVV does not reflect clinically relevant disease activity or progression. To minimize exposure to immunosuppression and in the face of negative blood culture, clinically quiescent arteritis, normal or stably raised C-reactive protein levels, we elected not to escalate treatment and monitor progression with MRA
- …